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Abstract The most dramatic, but seldom mentioned, difference
between alkaloid and peptide opioids is the change of chirality of
the K carbon of the tyramine moiety. We propose that the
presence of Gly2 or D-Ala2 in the two most common message
domains compensates this change by allowing the attainment of
unusual conformations. A thorough conformational search of
Tyr-D-Ala-Phe-NH-CH3 and of its isomer Tyr-L-Ala-Phe-NH-
CH3 backs this view and establishes a solid link between alkaloid
and peptide opioids. This finding supports the notion that
morphine, like other neurologically active plant compounds,
may bind to endogenous receptors in plants to regulate cell-to-
cell signaling systems.
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1. Introduction
Plants produce many complex molecules that are neurolog-
ically active; that is, they interact with speci¢c receptors in the
nervous system of animals. The prevailing opinion on the role
of these substances has assigned them a defensive function
against herbivore animals. This view is seriously challenged
by the recent discovery of putative glutamate receptors in
plants [1]. Although the possibility of a ‘plant nervous system’
is still farfetched, it seems fair to hypothesize that neurologi-
cally active compounds such as ca¡eine, cocaine and mor-
phine may act as ligands for endogenous receptors in plants
to regulate cell-to-cell signaling systems [1]. This ¢nding em-
phasizes the need for a better understanding of the relation-
ship between neurologically active plant compounds and their
animal counterparts.
In this respect, the most interesting case is probably that of
opioids, both for their practical relevance as drugs and for the
fact that alkaloid opioids, belonging to the family of mor-
phine, were known long before the identi¢cation of the cor-
responding peptide hormones synthesized by animal cells.
Since the discovery of enkephalins [2], the availability of a
very large number of synthetic analogues of both alkaloid
and peptide opioids has favored the collection of a huge
body of information on the relationship between primary
structure and biological activity (SAR) [3,4] albeit with limited
‘cross talk’ between the two ¢elds. Indeed, there are several
common characteristics between alkaloid and peptide opioids,
but also signi¢cant di¡erences. Nearly all opioids have part or
all of these features: two aromatic rings in a precise spatial
disposition, one enol group, and a basic center. In fact, three
of these features are embedded in the tyramine moiety that,
with the exception of a few synthetic compounds, is common
to nearly all opioids. Some of these features may be missing,
e.g. the second aromatic ring is not present in morphine,
whereas additional features may enhance binding and/or se-
lectivity, e.g. negative charges in N selective peptides and pos-
itive charges in U selective peptides. Natural peptide opioids
have recognition sequences, termed ‘message domain’ by R.
Schwyzer [5] all containing two aromatic residues, Tyr and
Phe. These are key residues since their relative spatial position
may regulate even receptor selectivity [6]. It is puzzling that
the ‘bioactive shape’ of alkaloids containing two aromatic
rings [6], so sensitive to small changes in the relative orienta-
tion of the two rings, can be simulated by peptide sequences in
which the two aromatic amino acids are separated either by
two residues, e.g. the Tyr-Gly-Gly-Phe message domain of
enkephalins, or just one, e.g. the Tyr-D-Ala-Phe message do-
main of dermorphin and deltorphin I [7].
The most dramatic di¡erence is the fact that the chirality of
the K carbon of the tyramine moiety in morphine alkaloids is
opposite with respect to that of the corresponding carbon
atom in L-Tyr, the initial residue in nearly all opioid peptides
[8^10]. In spite of its obvious relevance, this inversion of chir-
ality has received little attention in comparisons between al-
kaloid and peptide opioids. The di¡erence between alkaloids
and opioids is even more puzzling if one considers that the
whole molecule of morphine is essentially derived from two
molecules of L-tyrosine [10]. In addition, cyclization imposes
on the M1 of tyramine a value of 390‡ that appears to be
essential for opioid activity [9]. The topology requirements
imposed by the di¡erent chirality of the K carbon of the tyr-
amine moiety and by the rigid sca¡old of morphine alkaloids
may be achieved in enkephalin, via an induced ¢t with the
receptor, thanks to the extreme £exibility a¡orded by the two
Gly residues [11^13], including the ability of Gly to assume P,
i values typical of D-amino acids. The role of the two glycines
is played by a single D-amino acid in the potent opioid pep-
tides extracted from the skin of South American frogs, which
all contain a D-Xaa at the second position of the message
domain (Tyr-D-Xaa-Phe) [7,14]. However, the possibility
that D-Xaa2 may confer £exibility comparable to that of
Gly is ruled out by the fact that, in addition to D-Ala, bulky
residues such as D-Met, D-Leu or D-Val can be found in the
second position of deltorphins [7,14]. The presence of D-Xaa2
in the sequence Tyr-Xaa-Phe may allow the attainment of
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(bioactive) conformations that are not readily accessible to
Tyr-L-Xaa-Phe and that are consistent with the rigid sca¡old
of alkaloid opioids. We have performed a thorough confor-
mational search of the tripeptide Tyr-D-Ala-Phe-NH-CH3
(henceforth called YaF), and of its isomer Tyr-L-Ala-Phe-
NH-CH3 (henceforth called YAF) to check whether energy
accessible conformers are consistent with the topological re-
quirements imposed by the chirality of the K carbon of tyr-
amine and with the very rigid constraints imposed to the tyr-
amine moiety by cyclization. The alkaloid chosen for
comparison was 7-spiroindanyloxymorphine (SIOM), the ¢rst
non-peptide N opioid agonist [15] that similar to all natural
peptide opioids, is characterized by the presence of two aro-
matic rings. In addition, apart from the second aromatic ring,
SIOM and morphine have virtually identical common moi-
eties .
2. Methods
Starting structures of H2N-YAF-NH-CH3 and H2N-YaF-NH-CH3
were generated in fully extended conformations with the InsightII
molecular modeling system (Biosym/MS, San Diego, CA, USA). All
simulations were performed with the GROMOS program [16] and its
standard force ¢eld with explicit polar hydrogens. The leap-frog algo-
rithm was used to integrate the equations of motion with a 1 fs time
step. Bonds between atoms were kept ¢xed by the SHAKE procedure
[17] with a relative tolerance of 1033. Non-bonded interactions were
handled using a twin-range method [18] with a short and long cut-o¡
radius of 0.8 and 1.0 nm respectively. The non-bonded pair list was
updated every 20 fs. A dihedral potential with a force constant of
1000 kJ/mol was applied to enforce when necessary P, i angles.
3. Results
In order to ¢nd the conformational preferences of these two
model peptides we can reasonably limit our search to a con-
formational space of eight torsion angles, Tyr i1, Ala P2, i2,
Phe P3 and the Ms of Tyr and Phe since the i of Phe is
unin£uential with respect to the relative orientation of the
two aromatic rings. Even restricting the search to staggered
conformers of all Ms (i.e. g3, g and t) and using a grid mesh
of 30‡ for the backbone angles, the number of conformations
to calculate is discouragingly high. Therefore we resorted to a
stepwise approach that could lead to a progressive narrowing
of the space to examine.
A preliminary exhaustive search of the conformational
space span by the central Ala residues (L-Ala or D-Ala) was
performed by restraining (P2, i2) at a prede¢ned value while
minimizing the energy with respect to all other internal coor-
dinates. The need of ful¢lling two obvious requirements im-
posed by comparison with any rigid alkaloid led to the intro-
duction of two further restraints (see Section 2 and Fig. 1
caption). A meaningful comparison of the tripeptides with
morphine alkaloids implies a limited range of values for i1,
centered around a trans value since, owing to the length of the
peptide, values of i1 outside the range 330‡ to 120‡ would
prevent the ring of Phe from coming even close to the second
aromatic ring of SIOM for any combination of the other
torsion angles. In addition, the M11 of Tyr must have a g
value, consistent with the value found in morphine alkaloids,
since it was shown [9] that a change of M11 from 393‡ (typical
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Fig. 1. Conformationally available space for the central residue of the two tripeptides. Calculated Ramachandran plots for YAF and YaF (a
and c respectively) with a grid of 30‡ in P, i. Dihedral angles have been restrained to the mapped values, while the P, and M of Tyr1 were re-
stricted to values of 390‡ and 3170‡ respectively. The force constant for all dihedral restraints is of 1000 kJ/mol. After energy minimization,
molecular dynamics in vacuo of 100 ps for each grid point has been performed. Displayed points correspond to snapshots sampled every 1 ps.
Time evolution of unrestrained simulations of the P, i angles for YAF (b) and YaF (d) respectively. Starting con¢gurations have been chosen
in the C7 regions of plots (a) and (c) and energy minimized before starting the unrestrained simulation. Displayed points correspond to snap-
shots sampled every 1 ps.
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of morphine and SIOM) to 180‡ (typical of apomorphine)
prevents opioid activity.
Fig. 1 (a, c) shows the P, i distributions for the central
residue of YAF and YaF respectively, as calculated from Mo-
lecular Dynamics simulations. Areas of higher population
density are mainly observed in two quasi-antisymmetrical re-
gions of the plots. The centers of gravity of these regions
correspond to the well-known C7 conformations (C73=,
PW370‡, iW70‡, and C7=3, PW70‡, iW370‡) [19,20].
Antisymmetry can be observed also for other regions of the
maps, an indication that the change in chirality of the central
residue has a profound e¡ect on the conformational prefer-
ences of the whole molecule. Such a result is far from obvious,
i.e. it is not a trivial consequence of the di¡erent chirality of
the central residues, since the two peptides are not enantiom-
ers and all degrees of freedom of the molecule (but P2, i2)
have been left free to evolve during simulations. Fig. 1b,d
shows the time evolution of the P, i angles for YAF and
YaF respectively. Starting con¢gurations have been chosen
in the C7 regions of plots (a) and (c) and energy minimized
before starting a long unrestrained simulation. The energy
di¡erence between the two C7 minima is sensibly lower for
YaF than for YAF (vE=5.2 kJ/mol vs. 19.5 kJ/mol). The
conformational landscape is £atter and the number of transi-
tions between the two minima is higher, as can be seen in Fig.
1b,d. All these considerations indicate that YaF is a more
£exible and adaptable molecule.
The two highly populated conformers for YaF and YAF
were ¢nally compared with SIOM to check whether they are
equally consistent with the relative location of the aromatic
pharmacophores of a rigid opioid. Fig. 2 shows the overlays
of YaF (a) and YAF (b) with SIOM obtained by ¢tting all
heavy atoms of the tyramine moiety, with the exception of
ortho and meta carbons of the aromatic ring. It is easy to
see that only the peptide containing D-Ala2 allows a good
superposition of the second aromatic ring whereas the Phe3
ring of YAF and the corresponding ring of SIOM are spaced
in far away regions of space.
4. Discussion
Incorporation of D-amino acids in natural peptides, ob-
served in some bacterial antibiotics, takes place without the
participation of messenger RNAs and ribosomes [21]. In the
case of all opioid peptides extracted from the skin of south
american frogs [7], that are characterized by a Tyr-D-Xaa-Phe
message domain, cDNA cloning [22] has shown that a normal
codon for the corresponding L-amino acid is present in the
prepropeptide. This implies that the D-residues are formed
from L-amino acids by a posttranslational reaction [23]. The
need for a costly path, such as conversion from L-Ala to D-
Ala by a speci¢c isomerase [24], hints that the chirality change
may bear important energetic and/or conformational conse-
quences. In fact, it has been hypothesized that the role of the
D-Xaa may be to allow the attainment of unusual conforma-
tions [24,25]. A possible explanation borne out by the present
work, is that the change of chirality of the amino acid in the
second position is equivalent to the change of chirality of the
K carbon of the tyramine moiety in alkaloids and can in£u-
ence the conformation of the message domain, in particular
the relative arrangement of the aromatic rings of Tyr and Phe.
One may wonder why animals, like plants, do not simply
change the chirality of the K carbon of the tyramine moiety
to achieve the required topological features. However, the
stability of the chiral center towards unwanted racemization
is assured in morphine, by the rigid alkaloid sca¡old. On the
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Fig. 2. Comparisons of YaF (a) and YAF (b) with SIOM. The mo-
lecular model of SIOM is shown in part as dark green neon (scaf-
fold) and in part as a light green stick and ball representation (aro-
matic rings). The molecular models of the peptides are shown in
part as a dark violet stick and ball (backbone and alanine side
chain) and in part as a light violet stick and ball representation (ar-
omatic rings). The overlays were obtained by ¢tting the basic nitro-
gen, the K and L carbons, the enol oxygen and the aromatic car-
bons connected to and para to the oxygen of the corresponding
tyramine moieties of the peptide and SIOM.
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contrary, an K carbon adjacent to a free amino group, e.g. D-
Tyr as the ¢rst residue of a linear peptide, may be exposed to
random racemization more easily than the one of the second
residue (embedded in the peptide chain).
Our calculations strongly support the hypothesis of a con-
formational basis for the use of a D-amino acid residue in the
selection of bioactive conformations and establish a solid link
between alkaloid and peptide opioids. In turn, this result
paves the way to a reconsideration of the role of Gly or D-
Xaa residues in the conformation-activity relationship of nat-
ural peptides.
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